Burgess in the News

Dr. Burgess' Op-Ed: EPA could waive ban on Primatene Mist inhalers for asthmatics

| Posted in Burgess in the News

For years I have used a common over-the-counter emergency asthma inhaler called Primatene Mist. Like many asthma sufferers who find themselves awake at 2am with an unexpected asthma attack and do not have immediate access to an inhaler, Primatene Mist has been a simple and safe solution to what would otherwise be a costly and time-consuming emergency room visit. Unfortunately this past January, Primatene Mist was forced off pharmacy shelves due to an international treaty agreement known as the Montreal Protocol.

Working to ensure there will be no more Solyndras

| Posted in Burgess in the News

With millions out of work and rising prices on basic living expenses, American families are struggling across this country just to make ends meet. They have sent their representatives to Washington to ensure that their voices are heard, and that their tax dollars are used wisely. When this doesn’t happen, Congress must hold the proper people accountable, and do everything in our power to ensure that the waste stops and never happens again. The Obama administration’s decision to give a $535 million loan guarantee to Solyndra, when the writing was on the wall about the company’s troubled financial condition, is just the kind of waste that shouldn’t happen – and that Congress should take every step to prevent.

Dr. Burgess' Op-Ed: We cannot afford to forget Alzheimer's

| Posted in Burgess in the News

What devastation the affliction of Alzheimer’s can cause — it can take one’s life, to be sure, but even more insidious, it can remove a lifetime of memories and destroy the very essence of self. On Nov. 5, 1994, former President Reagan announced that he had Alzheimer’s. “I now begin the journey that will lead me into the sunset of my life,” he said in the letter. At that time, four million Americans suffered from the disease. Today, more than five million Americans live with Alzheimer’s, and this year alone, $200 billion will be spent caring for those with the disease.